(Q38970335)

8 September 2017

1 reference

title

Azole resistance in Candida (English)

1 reference

8 September 2017

Denning DW

1

1 reference

8 September 2017

Baily GG

series ordinal

2

1 reference

8 September 2017

Hood SV

series ordinal

3

1 reference

8 September 2017

publication date

1 April 1997

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

8 September 2017

published in

1 reference

8 September 2017

volume

16

1 reference

8 September 2017

issue

4

1 reference

8 September 2017

page(s)

261-280

1 reference

Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Comparison of in vivo activity of fluconazole with that of amphotericin B against Candida tropicalis, Candida glabrata, and Candida krusei

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Antifungal susceptibility testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. The Norwegian Yeast Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Collaborative investigation of variables in susceptibility testing of yeasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Antifungal susceptibility tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Standardized susceptibility testing of fluconazole: an international collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Fluconazole susceptibility testing of Candida albicans: microtiter method that is independent of inoculum size, temperature, and time of reading

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Development of resistance in candida isolates from patients receiving prolonged antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Improved medium for fluconazole susceptibility testing of Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum size

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Innovative endpoint determination system for antifungal susceptibility testing of yeasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Activities of fluconazole (UK 49,858) and ketoconazole against ketoconazole-susceptible and -resistant Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Correlation between in vitro and in vivo activity of antifungal agents against Candida species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Clinically significant mucosal candidiasis resistant to fluconazole treatment in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Characterization of an azole-resistant Candida glabrata isolate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Opportunistic candidiasis: an epidemic of the 1980s.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Fluconazole-resistant Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Molecular epidemiology of recurrent oral candidiasis in human immunodeficiency virus-positive patients: evidence for two patterns of recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Isolation of fluconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Isolation of Candida norvegensis from clinical specimens: four case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Symptomatic vulvovaginitis due to fluconazole-resistant Candida albicans in a female who was not infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Increased gastric pH and the bioavailability of fluconazole and ketoconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Interaction of Azoles with Rifampin, Phenytoin, and Carbamazepine: In Vitro and Clinical Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01695630

Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

21 January 2018

1 reference

12 December 2020

The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance

1 reference

12 December 2020

Altered P450 activity associated with direct selection for fungal azole resistance

1 reference

12 December 2020

[In vitro evaluation of the sensitivity to fluconazole of different species of yeasts isolated in pathology]

1 reference

12 December 2020

Molecular mechanisms of drug resistance in fungi

1 reference

12 December 2020

Collaborative investigation of broth microdilution and semisolid agar dilution for in vitro susceptibility testing of Candida albicans

1 reference

12 December 2020

Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection.

1 reference

12 December 2020

In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole

1 reference

12 December 2020

In vitro susceptibility and sterol biosynthesis of Candida albicans strains after long-term treatment with azoles in HIV-infected patients

1 reference

12 December 2020

Initial use of a broth microdilution method suitable for in vitro testing of fungal isolates in a clinical microbiology laboratory

1 reference

12 December 2020

Management of deep Candida infection in surgical and intensive care unit patients. British Society for Antimicrobial Chemotherapy Working Party

1 reference

12 December 2020

Correlation of in-vitro susceptibility test results with clinical response: a study of azole therapy in AIDS patients.

1 reference

12 December 2020

Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome

1 reference

12 December 2020

Itraconazole cyclodextrin solution--effective treatment for HIV-related candidosis unresponsive to other azole therapy

1 reference

12 December 2020

Mode of action and resistance to azole antifungals associated with the formation of 14 alpha-methylergosta-8,24(28)-dien-3 beta,6 alpha-diol.

1 reference

12 December 2020

Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans.

1 reference

12 December 2020

An evaluation of seven methods of testing in vitro susceptibility of clinical yeast isolates to fluconazole

1 reference

12 December 2020

In vitro activity of BMS-181184 compared with those of fluconazole and amphotericin B against various candida spp

1 reference

12 December 2020

Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients

1 reference

12 December 2020

Molecular karyotyping of multiple yeast species isolated from nine patients with AIDS during prolonged fluconazole therapy.

1 reference

12 December 2020

The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection

1 reference

12 December 2020

Comparative resistance of Candida albicans clinical isolates to fluconazole and itraconazole in vitro and in vivo in a murine model.

1 reference

12 December 2020

In vitro studies of activities of the antifungal triazoles SCH56592 and itraconazole against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts

1 reference

12 December 2020

High prevalence of antifungal resistance in Candida spp. from patients with AIDS.

1 reference

12 December 2020

Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing

1 reference

12 December 2020

Successful treatment of chronic mucocutaneous candidiasis with ketoconazole

1 reference

12 December 2020

Relative growth measurement of Candida species in a single concentration of fluconazole predicts the clinical response to fluconazole in HIV infected patients with oral candidosis

1 reference

12 December 2020

Antifungal activity of a new triazole, D0870, compared with four other antifungal agents tested against clinical isolates of Candida and Torulopsis glabrata

1 reference

12 December 2020

Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests

1 reference

12 December 2020

Clinical and microbiological characteristics of symptomatic vulvovaginal candidiasis in HIV-seropositive women.

1 reference

12 December 2020

Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals

1 reference

12 December 2020

Antifungal chemotherapy in patients with acquired immunodeficiency syndrome. British Society for Antimicrobial Chemotherapy Working Party

1 reference

12 December 2020

Relative inhibition factors--a novel approach to the assessment of antifungal antibiotics in vitro

1 reference

12 December 2020

Fluconazole in the management of fungal urinary tract infections.

1 reference

12 December 2020

Itraconazole susceptibilities of fluconazole susceptible and resistant isolates of five Candida species

1 reference

12 December 2020

New drugs for systemic fungal infections

1 reference

12 December 2020

Correlation between antifungal susceptibility testing of Candida isolates from patients with HIV infection and clinical results after treatment with fluconazole

1 reference

12 December 2020

High incidence of antifungal drug resistance in Candida tropicalis

1 reference

12 December 2020

In-vitro resistance to imidazole antifungals in Candida albicans

1 reference

12 December 2020

Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates.

1 reference

12 December 2020

Multicenter comparison of a colorimetric microdilution broth method with the reference macrodilution method for in vitro susceptibility testing of yeast isolates

1 reference

12 December 2020

Modified response to ketoconazole of Candida albicans from a treatment failure

1 reference

12 December 2020

Genotype and phenotype of oral Candida albicans from patients infected with the human immunodeficiency virus

1 reference

12 December 2020

Efficacy of oral amphotericin B in AIDS patients with thrush clinically resistant to fluconazole.

1 reference

12 December 2020

Evaluation of antifungal activity of antimycotics by automatic analyzing system

1 reference

12 December 2020

Antifungal drug susceptibility testing. Working Party of the British Society for Antimicrobial chemotherapy

1 reference

12 December 2020

Opportunistic diseases reported in AIDS patients: frequencies, associations, and trends.

1 reference

12 December 2020

Resistance of yeasts to azole-derivative antifungals

1 reference

12 December 2020

Fluconazole resistance in AIDS patients

1 reference

12 December 2020

Resistance to fluconazole in Candida albicans from AIDS patients correlated with reduced intracellular accumulation of drug

1 reference

12 December 2020

Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B

1 reference

12 December 2020

Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients.

1 reference

12 December 2020

Treatment of Candida albicans fungaemia with fluconazole

1 reference

12 December 2020

Fluconazole resistant candida in AIDS

1 reference

12 December 2020

Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis

1 reference

12 December 2020

Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome

1 reference

12 December 2020

Resistance to fluconazole and amphotericin in Candida albicans from AIDS patients

1 reference

12 December 2020

Resistance of clinically important yeasts to antifungal agents

1 reference

12 December 2020

Comparison of D0870, a new triazole antifungal agent, to fluconazole for inhibition of Candida albicans cytochrome P-450 by using in vitro assays

1 reference

12 December 2020

DNA subtypes and fluconazole susceptibilities of Candida albicans isolates from the oral cavities of patients with AIDS

1 reference

12 December 2020

Treatment and secondary prophylaxis with fluconazole for oropharyngeal candidiasis in HIV-positive patients. A mycological analysis of failures

1 reference

12 December 2020

Multicenter evaluation of four methods of yeast inoculum preparation

1 reference

12 December 2020

Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients.

1 reference

12 December 2020

Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole.

1 reference

12 December 2020

Fluconazole in the treatment of oropharyngeal candidosis in HIV-positive patients

1 reference

12 December 2020

Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group

1 reference

12 December 2020

Typing Candida albicans oral isolates from human immunodeficiency virus-infected patients by multilocus enzyme electrophoresis and DNA fingerprinting

1 reference

12 December 2020

Evaluation of the E test system versus a microtitre broth method for antifungal susceptibility testing of yeasts against fluconazole and itraconazole

1 reference

12 December 2020

Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.

1 reference

12 December 2020

The activity in vitro and in vivo of a new imidazole antifungal, ketoconazole

1 reference

12 December 2020

Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome

1 reference

12 December 2020

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute

1 reference

12 December 2020

Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study

1 reference

12 December 2020

Esophageal ulcers caused by Torulopsis glabrata in a patient with acquired immune deficiency syndrome

1 reference

12 December 2020

Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis

1 reference

12 December 2020

Comparison study of broth macrodilution and microdilution antifungal susceptibility tests

1 reference

12 December 2020

Candida albicans resistance in AIDS

1 reference

12 December 2020

Origin of differences in susceptibility of Candida krusei to azole antifungal agents

1 reference

12 December 2020

Correlation between in vitro resistance to fluconazole and clinical outcome of oropharyngeal candidiasis in HIV-infected patients.

1 reference

12 December 2020

Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study

1 reference

12 December 2020

An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections in patients treated for hematological malignancy

1 reference

12 December 2020

Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance

1 reference

12 December 2020

Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients

1 reference

12 December 2020

Evaluation of a broth microdilution antifungal susceptibility test with a pH indicator: comparison with the broth macrodilution procedures

1 reference

12 December 2020

Mixed oropharyngeal candidiasis due to Candida albicans and non-albicans Candida strains in HIV-infected patients

1 reference

12 December 2020

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

1 reference

12 December 2020

Fluconazole-resistant candidosis in an HIV cohort.

1 reference

12 December 2020

Etest for antifungal susceptibility testing of yeasts

1 reference

12 December 2020

Molecular epidemiology of Candida isolates from AIDS patients showing different fluconazole resistance profiles

1 reference

12 December 2020

An analysis of the trends in the use of antifungal drugs and fungal isolates in a UK University Hospital

1 reference

12 December 2020

Inhibition and interaction of cytochrome P450 of Candida krusei with azole antifungal drugs

1 reference

12 December 2020

Relationship between fluconazole sensitivity of Candida albicans isolates from HIV positive patients and serotype, adherence and CD4+ lymphocyte count.

1 reference

12 December 2020

Tablet sensitivity testing on pathogenic fungi

1 reference

12 December 2020

Strain delineation and epidemiology of Candida (Clavispora) lusitaniae

1 reference

12 December 2020

Comparison of broth macrodilution, broth microdilution, and E test antifungal susceptibility tests for fluconazole

1 reference

12 December 2020

Fluconazole therapy of oral candidiasis in HIV-infected patients: results of a multicentre study

1 reference

12 December 2020

Management of genital candidiasis. Working Group of the British Society for Medical Mycology

1 reference

12 December 2020

Test methods for antifungal agents--a critical review

1 reference

12 December 2020

A rapid [3H]glucose incorporation assay for determination of lymphoid cell-mediated inhibition of Candida albicans growth

1 reference

12 December 2020

Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine

1 reference

12 December 2020

Risk factors associated with candidemia in the neonatal intensive care unit: a case-control study

1 reference

12 December 2020

Rapid determination of antifungal activity by flow cytometry.

1 reference

12 December 2020

Fluconazole resistance in Candida glabrata

1 reference

12 December 2020

In vitro activity of amphotericin B, flucytosine and fluconazole against yeasts causing bloodstream infections

1 reference

12 December 2020

Use of Fluconazole Is Not Associated with a Higher Incidence of Candida krusei and Other Non-albicans Candida Species

1 reference

12 December 2020

Fluconazole resistant candida in AIDS.

1 reference

12 December 2020

[Laboratory's controls of antifungal treatment by the fluconazole of the candidiasis in immunocompromised patients]

1 reference

12 December 2020

Oropharyngeal yeast flora and fluconazole resistance in HIV-infected patients receiving long-term continuous versus intermittent fluconazole therapy.

1 reference

12 December 2020

Fluconazole resistance in Candida in patients with AIDS--a therapeutic approach

1 reference

12 December 2020

Susceptibility of Candida albicans and other yeasts to fluconazole: relation between in vitro and in vivo studies

1 reference

12 December 2020

Improved method of determining the susceptibility of Candida albicans to fluconazole

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01695630

1 reference

Dimensions Publication ID

8 September 2017

1025257128

0 references

1 reference